Well, I'm trying to think of reasons for the decline over the last 3 days.
In Kris Knauer's recent interview, 2 or 3 days ago, he mentioned:
FDA approval hopefully by first quarter 2017
$4.3mil in the bank, with a cash burn rate of $800k/quarter
Possible funds raising late 2016/early 2017
Only dealing with big insurers and wellness companies, leaving it up to the wellness companies to sell on the technology. So no hints at Google, Apple etc jumping on board.
I know there were a lot of positive points too, but maybe this isn't going to be the instant money maker some investors were looking for. As far as the depression test is concerned, with FDA approval being possibly over a year away, and fund raising on the horizon, there are other places to put your money.
As for the stress test, maybe the upside will be somewhat more imminent
MEB Price at posting:
32.0¢ Sentiment: None Disclosure: Not Held
